Iris Plug: Clinical Trials

1 trial sponsored by Iris Plug, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Active not recruiting 1

Follow Iris Plug: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Avalglucosidase Alfa in Patients With Non-classic Pompe Disease Aged ≥ 5 Years
Avalglucosidase Alfa - Glycogen Storage Disease Type II Late Onset, Pompe Disease (Late-onset)
Phase 4Active not recruitingIris Plug62022-10-132026-06-17

Conditions studied

Glycogen Storage Disease Type II (1)

Countries

Netherlands (1)

Top investigators

Nadine van der Beek, MD PHD (1)

NIH funding

2019 (1)